Fresenius SE & Co. KGaA Stock Forecast, Price & News

-0.04 (-0.34 %)
(As of 04/15/2021 12:00 AM ET)
Today's Range
Now: $11.56
50-Day Range
MA: $11.06
52-Week Range
Now: $11.56
Volume22,833 shs
Average Volume33,447 shs
Market Capitalization$25.72 billion
P/E Ratio12.70
Dividend Yield1.47%
Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune diseases and oncology; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operated 89 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 46 hospitals, 70 outpatient clinics, and approximately 300 risk prevention centers in Spain. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project consulting and development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Fresenius SE & Co. KGaA logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Year Founded1912



Sales & Book Value

Annual Sales$39.66 billion
Cash Flow$2.14 per share
Book Value$13.38 per share


Net Income$2.11 billion


Outstanding Shares2,225,290,000
Market Cap$25.72 billion
Next Earnings Date5/5/2021 (Estimated)
OptionableNot Optionable


Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Stock Price Up 0.2%
April 7, 2021 |  americanbankingnews.com
Is FRESENIUS SE&CO (FSNUY) a Great Value Stock Right Now?
February 8, 2021 |  finance.yahoo.com
Are Investors Undervaluing Fresenius (FMS) Right Now?
December 30, 2020 |  finance.yahoo.com
Fresenius SE & Co. KGaA ADR
December 26, 2020 |  wsj.com
Fresenius Q3 2020 In-Depth Review
October 29, 2020 |  seekingalpha.com
Fresenius Medical Care earnings: here's what Wall Street expects
October 29, 2020 |  markets.businessinsider.com
Here's what to expect from Fresenius SE's earnings report
October 28, 2020 |  markets.businessinsider.com
Fresenius Is Too Cheap To Ignore
October 28, 2020 |  seekingalpha.com
Fresenius Medical Care's Unexciting Capital Markets Day
October 16, 2020 |  seekingalpha.com
See More Headlines


Overall MarketRank

1.42 out of 5 stars

Medical Sector

629th out of 2,025 stocks

Surgical & Medical Instruments Industry

60th out of 169 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 3.1 5 -4 -3 -2 -1 -
-0.04 (-0.34 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FSNUY News and Ratings via Email

Sign-up to receive the latest news and ratings for FSNUY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Frequently Asked Questions

Is Fresenius SE & Co. KGaA a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last year. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Fresenius SE & Co. KGaA stock.
View analyst ratings for Fresenius SE & Co. KGaA
or view top-rated stocks.

What stocks does MarketBeat like better than Fresenius SE & Co. KGaA?

Wall Street analysts have given Fresenius SE & Co. KGaA a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Fresenius SE & Co. KGaA wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA saw a decrease in short interest in March. As of March 31st, there was short interest totaling 6,100 shares, a decrease of 50.0% from the March 15th total of 12,200 shares. Based on an average daily volume of 50,400 shares, the days-to-cover ratio is currently 0.1 days.
View Fresenius SE & Co. KGaA's Short Interest

When is Fresenius SE & Co. KGaA's next earnings date?

Fresenius SE & Co. KGaA is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Fresenius SE & Co. KGaA

How were Fresenius SE & Co. KGaA's earnings last quarter?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) released its earnings results on Tuesday, February, 23rd. The company reported $0.26 EPS for the quarter. The firm had revenue of $11.10 billion for the quarter. Fresenius SE & Co. KGaA had a net margin of 4.99% and a trailing twelve-month return on equity of 6.74%.
View Fresenius SE & Co. KGaA's earnings history

How has Fresenius SE & Co. KGaA's stock been impacted by COVID-19?

Fresenius SE & Co. KGaA's stock was trading at $10.13 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, FSNUY shares have increased by 14.1% and is now trading at $11.56.
View which stocks have been most impacted by COVID-19

How often does Fresenius SE & Co. KGaA pay dividends? What is the dividend yield for Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA declared an annual dividend on Friday, July 10th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.16 per share on Thursday, September 10th. This represents a dividend yield of 1.28%. The ex-dividend date is Monday, August 31st. This is an increase from Fresenius SE & Co. KGaA's previous annual dividend of $0.15.
View Fresenius SE & Co. KGaA's dividend history

Is Fresenius SE & Co. KGaA a good dividend stock?

Fresenius SE & Co. KGaA pays an annual dividend of $0.17 per share and currently has a dividend yield of 1.47%. The dividend payout ratio of Fresenius SE & Co. KGaA is 18.09%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Fresenius SE & Co. KGaA will have a dividend payout ratio of 16.35% next year. This indicates that Fresenius SE & Co. KGaA will be able to sustain or increase its dividend.
View Fresenius SE & Co. KGaA's dividend history.

Who are Fresenius SE & Co. KGaA's key executives?

Fresenius SE & Co. KGaA's management team includes the following people:
  • Mr. Stephan Sturm, CEO, Pres & Chairman of Management Board - Fresenius Management SE (Age 58, Pay $4.19M)
  • Ms. Rachel Clare Empey, CFO & Member of Management Board - Fresenius Management SE (Age 45, Pay $3.35M)
  • Dr. Francesco De Meo, Member of Management Board - Fresenius Management SE (Age 58, Pay $2.88M)
  • Dr. Ernst Wastler, Member of Management Board - Fresenius Management SE (Age 63, Pay $1.86M)
  • Mr. Rice Powell, Member of Management Board - Fresenius Management SE (Age 66, Pay $4.77M)
  • Dr. Sebastian Biedenkopf, Chief Legal & Compliance Officer, Insurance, HR, Labor Relations Director and Member of Mgmt. Board (Age 56, Pay $710.82k)
  • Mr. Markus Georgi, Sr. VP of Investor Relations

Who are some of Fresenius SE & Co. KGaA's key competitors?

What is Fresenius SE & Co. KGaA's stock symbol?

Fresenius SE & Co. KGaA trades on the OTCMKTS under the ticker symbol "FSNUY."

How do I buy shares of Fresenius SE & Co. KGaA?

Shares of FSNUY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius SE & Co. KGaA's stock price today?

One share of FSNUY stock can currently be purchased for approximately $11.56.

How much money does Fresenius SE & Co. KGaA make?

Fresenius SE & Co. KGaA has a market capitalization of $25.72 billion and generates $39.66 billion in revenue each year. The company earns $2.11 billion in net income (profit) each year or $0.94 on an earnings per share basis.

How many employees does Fresenius SE & Co. KGaA have?

Fresenius SE & Co. KGaA employs 311,269 workers across the globe.

When was Fresenius SE & Co. KGaA founded?

Fresenius SE & Co. KGaA was founded in 1912.

What is Fresenius SE & Co. KGaA's official website?

The official website for Fresenius SE & Co. KGaA is www.fresenius.com.

Where are Fresenius SE & Co. KGaA's headquarters?

Fresenius SE & Co. KGaA is headquartered at Else-Kroner-Strasse 1, Bad Homburg 2M, 61352.

How can I contact Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The company can be reached via phone at 49-6172-6080 or via email at [email protected]

This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.